Evidence map›Paper›PMID 23236583›Full record

ArticleJournal of venom research2012

Nanoparticle-conjugated animal venom-toxins and their possible therapeutic potential.

Archita Biswas, Aparna Gomes, Jayeeta Sengupta, Poulami Datta, Santiswarup Singha, Anjan Kr Dasgupta, Antony Gomes

Abstract read
In one paragraph

Article in Journal of venom research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Chitosan-Nanomaterials (Basel, Switzerland) · 2025
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. The Influence of Silver Nanoparticles Against Toxic Effects ofInternational journal of nanomedicine · 2021
    Article
  10. Article
  11. Anticancer potential of nanogold conjugated toxin GNP-NN-32 fromThe journal of venomous animals and toxins including tropical diseases · 2020
    Article
  12. Review
  13. Article
  14. Article
  15. Epidemiological review of scorpion envenomation in iran.Iranian journal of pharmaceutical research : IJPR · 2014
    Review
  16. Toxicology reports · 2014
    Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Archita BiswasDrug Development/Diagnostics and Biotechnology Division, Indian Institute of Chemical Biology, 4 Raja SC Mullick Road, Kolkata - 700 032, Kolkata, India.
Aparna Gomes
Jayeeta Sengupta
Poulami Datta
Santiswarup Singha
Anjan Kr Dasgupta
Antony Gomes
Indian Institute of Chemical Biology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nano-medical approaches to develop drugs have attracted much attention in different arenas to design nanoparticle conjugates for better efficacy of the potential bio-molecules. A group of promising candidates of this category would be venom-toxins of animal origin of potential medicinal value. Traditional systems of medicine as well as folklores mention the use of venom-toxins for the treatment of various diseases. Research has led to scientific validation of medicinal applications of venoms-toxins and many active constituents derived from venoms-toxins are already in clinical use or under clinical trial. Nanomedicine is an emerging field of medicine where nanotechnology is used to develop molecules of nano-scale dimension, so that these molecules can be taken up by the cells more easily and have better efficacy, as compared to large molecules that may tend to get eliminated. This review will focus on some of the potential venoms and toxins along with nanoparticle conjugated venom-toxins of snakes, amphibians, scorpions and bees, etc., for possible therapeutic clues against emerging diseases.

Indexed as

nano-conjugationnano-medicinenano-particlesnano-technologytherapeutic potentialtoxinsVenoms

Identifiers

PMID23236583
PMCPMC3518302
OpenAlexW1749433136

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.